Literature DB >> 29193623

Cognitive and behavioral phenotype of children with pseudohypoparathyroidism type 1A.

Katia M Perez1, Evon B Lee2, Sachini Kahanda3, Jessica Duis4, Monica Reyes5, Harald Jüppner5, Ashley H Shoemaker3.   

Abstract

Pseudohypoparathyroidism 1A (PHP1A) is a rare, genetic disorder. Most patients with PHP1A have cognitive impairment but this has not been systematically studied. We hypothesized that children with PHP1A would have lower intelligent quotient (IQ) scores than controls. To evaluate cognition and behavior, we prospectively enrolled children with PHP1A, one unaffected sibling (when available) and controls matched on BMI/age/gender/race. Evaluations included cognitive and executive function testing. Parents completed questionnaires on behavior and executive function. We enrolled 16 patients with PHP1A, 8 unaffected siblings, and 15 controls. Results are presented as mean (SD). The PHP1A group had a composite IQ of 85.9 (17.2); 25% had a composite IQ < -2 SD. The PHP1A group had significantly lower IQs than matched controls (composite IQ -17.3, 95%CI -28.1 to -6.5, p < 0.01) and unaffected siblings (composite IQ -21.5, 95%CI -33.9 to -9.1, p < 0.01). Special education services were utilized for 93% of the patients with PHP1A. Deficits were observed in executive function and parents reported delayed adaptive behavior skills and increased rates of attention deficit hyperactivity disorder. In conclusion, children with PHP1A have lower intelligence quotient scores, poorer executive function, delayed adaptive behavior skills, and increased behavior problems.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Albright hereditary osteodystrophy; cognition; pseudohypoparathyroidism

Mesh:

Year:  2017        PMID: 29193623      PMCID: PMC5942181          DOI: 10.1002/ajmg.a.38534

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  Test review: Delis-Kaplan executive function system.

Authors:  Susan Homack; Donghyung Lee; Cynthia A Riccio
Journal:  J Clin Exp Neuropsychol       Date:  2005-07       Impact factor: 2.475

Review 2.  Practitioner review: do performance-based measures and ratings of executive function assess the same construct?

Authors:  Maggie E Toplak; Richard F West; Keith E Stanovich
Journal:  J Child Psychol Psychiatry       Date:  2012-10-11       Impact factor: 8.982

3.  Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.

Authors:  Susanne Thiele; Luisa de Sanctis; Ralf Werner; Joachim Grötzinger; Cumhur Aydin; Harald Jüppner; Murat Bastepe; Olaf Hiort
Journal:  Hum Mutat       Date:  2011-04-12       Impact factor: 4.878

4.  Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy.

Authors:  L C Wilson; M E Oude Luttikhuis; P T Clayton; W D Fraser; R C Trembath
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

Review 5.  Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity).

Authors:  Adele Diamond
Journal:  Dev Psychopathol       Date:  2005

6.  Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.

Authors:  Murat Bastepe; Leopold F Fröhlich; Geoffrey N Hendy; Olafur S Indridason; Robert G Josse; Hiroyuki Koshiyama; Jarmo Körkkö; Jon M Nakamoto; Arlan L Rosenbloom; Arnold H Slyper; Toshitsugu Sugimoto; Agathocles Tsatsoulis; John D Crawford; Harald Jüppner
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

7.  Academic underachievement by people with Prader-Willi syndrome.

Authors:  J Whittington; A Holland; T Webb; J Butler; D Clarke; H Boer
Journal:  J Intellect Disabil Res       Date:  2004-02

8.  Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha.

Authors:  M Mouallem; M Shaharabany; N Weintrob; S Shalitin; N Nagelberg; H Shapira; Z Zadik; Z Farfel
Journal:  Clin Endocrinol (Oxf)       Date:  2007-09-04       Impact factor: 3.478

9.  The Prevalence of GNAS Deficiency-Related Diseases in a Large Cohort of Patients Characterized by the EuroPHP Network.

Authors:  Francesca Marta Elli; Agnès Linglart; Intza Garin; Luisa de Sanctis; Paolo Bordogna; Virginie Grybek; Arrate Pereda; Federica Giachero; Elisa Verrua; Patrick Hanna; Giovanna Mantovani; Guiomar Perez de Nanclares
Journal:  J Clin Endocrinol Metab       Date:  2016-07-18       Impact factor: 5.958

Review 10.  GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2014-11-28       Impact factor: 4.878

View more
  3 in total

1.  Glucose Homeostasis and Energy Balance in Children With Pseudohypoparathyroidism.

Authors:  Katia M Perez; Kathleen L Curley; James C Slaughter; Ashley H Shoemaker
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 2.  Management of pseudohypoparathyroidism.

Authors:  Emily L Germain-Lee
Journal:  Curr Opin Pediatr       Date:  2019-08       Impact factor: 2.856

Review 3.  Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Aurora Garcia Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen A T Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Manasori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebeca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Horm Res Paediatr       Date:  2020-08-05       Impact factor: 2.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.